CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print August 13, 2009
CA Cancer J Clin 2009
doi: 10.3322/caac.20028
© 2009 American Cancer Society
This Article
Right arrow Full Text Freely available
Right arrow Freely available CME: Take the course for this article:
Preoperative Magnetic Resonance Imaging (MRI) in Breast Cancer: Should MRI ...
Right arrow FREE NURSING CONTACT HOURS
Right arrow All Versions of this Article:
caac.20028v1
59/5/290    most recent
Right arrow Submit a letter to the editor
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Houssami, N.
Right arrow Articles by Hayes, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Houssami, N.
Right arrow Articles by Hayes, D. F.

Review of Preoperative Magnetic Resonance Imaging (MRI) in Breast Cancer: Should MRI Be Performed on All Women with Newly Diagnosed, Early Stage Breast Cancer?

Nehmat Houssami, MBBS, PhD1 and Daniel F. Hayes, MD2

1Associate Professor and Principal Research Fellow, Screening and Test Evaluation Program (STEP), School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia, and Breast Physician at the Royal Hospital for Women, Sydney, Australia
2Clinical Director of the Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Corresponding author: Nehmat Houssami, MBBS, PhD, Screening and Test Evaluation Program (STEP), School of Public Health, Edward Ford Building (A27), University of Sydney, NSW 2006, Australia; nehmath{at}med.usyd.edu.au

To earn free CME credit or nursing contact hours for successfully completing the online quiz based on this article, go to http://CME.AmCancerSoc.org.

DISCLOSURES: Nehmat Houssami is funded by National Health and Medical Research Council program grant no. 402764 to the Screening and Test Evaluation Program. Daniel F. Hayes is supported by the Fashion Footwear Charitable Foundation of New York/QVC Presents Shoes on Sale. No other potential conflict of interest relevant to this article was reported.

Randomized controlled trials have shown equivalent survival for women with early stage breast cancer who are treated with breast-conservation therapy (local excision and radiotherapy) or mastectomy. Decades of experience have demonstrated that breast-conservation therapy provides excellent local control based on defined standards of care. Magnetic resonance imaging (MRI) has been introduced in preoperative staging of the affected breast in women with newly diagnosed breast cancer because it detects additional foci of cancer that are occult on conventional imaging. The median incremental (additional) detection for MRI has been estimated as 16% in meta-analysis. In the absence of consensus on the role of preoperative MRI, we review data on its detection capability and its impact on treatment. We outline that the assumptions behind the adoption of MRI, namely that it will improve surgical planning and will lead to a reduction in re-excision surgery and in local recurrences, have not been substantiated by trials. Evidence consistently shows that MRI changes surgical management, usually from breast conservation to more radical surgery; however, there is no evidence that it improves surgical care or prognosis. Emerging data indicate that MRI does not reduce re-excision rates and that it causes false positives in terms of detection and unnecessary surgery; overall there is little high-quality evidence at present to support the routine use of preoperative MRI. Randomized controlled trials are needed to establish the clinical, psychosocial, and long-term effects of MRI and to show a related change in treatment from standard care in women newly affected by breast cancer. CA Cancer J Clin 2009. © 2009 American Cancer Society, Inc..




eLetters:

Read all eLetters

eLetter to "Review of Preoperative Magnetic Resonance Imaging (MRI) in Breast Cancer"
Lijun Yuan, et al.
CA Online, 16 Sep 2009 [Full text]
Concerns about the role of MRI in preoperative evaluation of breast cancer
Shaowei Liu, et al.
CA Online, 9 Oct 2009 [Full text]
MRI in patients with different risks
Juliang Zhang, et al.
CA Online, 12 Oct 2009 [Full text]
Several factors to ensure the application of breast MRI without increasing the rate of mastectomy
Nian-Song Qian, et al.
CA Online, 29 Oct 2009 [Full text]
Concerns about advocating preoperative MRI on breast cancer patients
Yunyou Duan, et al.
CA Online, 8 Feb 2010 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH
Copyright © 2009 by American Cancer Society.